| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.2 | 0.1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |